QuickView for SCF;jsessionid=0B2F1F06F0E5BEBBAD98C4DD9ABB7619;jsessionid=E640CDBA0BCD3C7C42251B7DCD1DA430;jsessionid=370E5773C1C0B001727A002357726D56;jsessionid=F14F327CB33B03E5E4ADE4B9C33A2EB9 (gene)

1. Calumenin knockdown, by intronic artificial microRNA, to improve expression efficiency of the recomb…
2. Creatine phosphate disodium salt protects against Dox-induced cardiotoxicity by increasing calumenin…
3. Protective effect of miR378* on doxorubicin-induced cardiomyocyte injury via calumenin.
4. CALU polymorphism A29809G affects calumenin availability involving vascular calcification.
5. Biophysical characterisation of calumenin as a charged F508del-CFTR folding modulator.

There were no clinical trials for SCF;jsessionid=0B2F1F06F0E5BEBBAD98C4DD9ABB7619;jsessionid=E640CDBA0BCD3C7C42251B7DCD1DA430;jsessionid=370E5773C1C0B001727A002357726D56;jsessionid=F14F327CB33B03E5E4ADE4B9C33A2EB9